SESSION 32 SCHEDULE
Saturday
SESSION 32: NEW DEVELOPMENTS IN ANEURYSMS AND THEIR TREATMENT: EVAR, THE TRIALS, LAPAROSCOPIC METHODS (5-MINUTE TALKS)
Moderators:Michael L. Marin, MD / Robert B. Rutherford, MD  
x
6:40 AM - 6:45 AM Anaconda Endograft For Juxtarenal AAAs: An “Off-the-Shelf” Solution To The Short (3-10 mm) Infrarenal Neck: Technical Details With The Possible Use Of Supplementary Stents
  Presenters(s):Randy D. Moore, MD  
6:46 AM - 6:51 AM Modifiable And Unmodifiable Predictors Of Preoperative Mortality And Morbidity In Open AAA Repair
  Presenters(s):Gregory L. Moneta, MD  
6:52 AM - 6:57 AM Best Strategy For Treating Huge AAAs > 15 cm In Diameter: Open vs. Endo
  Presenters(s):Jacques Busquet, MD  
6:58 AM - 7:03 AM Renal Artery Revascularization By Totally Laparoscopic Techniques
  Presenters(s):Jerome Cau, MD / Yves S. Alimi, MD  
7:04 AM - 7:09 AM Debate 22: Rupture After EVAR Is More Benign Than The Usual Ruptured AAA
  Presenters(s):James May, MD, MS, FRACS, FACS  
7:10 AM - 7:15 AM Debate 22: Rupture After EVAR Is Not More Benign Than The Usual Ruptured AAA
  Presenters(s):Michel S. Makaroun, MD  
7:16 AM - 7:21 AM New From The EVAR Trial: Mortality Catch-Up After EVAR: What Is It Due To?
  Presenters(s):Louise C. Brown, PhD / Roger M. Greenhalgh, MD / Janet T. Powell, MD, PhD  
7:22 AM - 7:27 AM How To Do Open AAA Repair Of Large AAAs Through A Tiny Incision
  Presenters(s):Tomislav Klokocovnik, PhD  
7:28 AM - 7:33 AM Panel Discussion
Moderator(s): K. Wayne Johnston, MD, FRCS / Frank J. Veith, MD  
7:33 AM - 7:38 AM Debate 23: Short-Term And Long-Term Outcomes After EVAR And Open Repair Of RAAAs From The Medicare Database: They Are Equally Bad For Open And Endo
  Presenters(s):Mark Conrad, MD  
7:39 AM - 7:44 AM Debate 23: Single Center Outcomes Of EVAR And Open Repair For Ruptured AAAs: The Short-Term Survival Benefit Of EVAR Is Sustained Long-Term
  Presenters(s):Dieter O. Mayer, MD  
7:45 AM - 7:50 AM More That Is New From The EVAR Trials: Rupture After EVAR Is More Common Than After Open Repair Of AAAs Shown In The EVAR UK Trials I And II
  Presenters(s):Thomas R. Wyss, MD / Louise C. Brown, PhD / Janet T. Powell, MD, PhD / Roger M. Greenhalgh, MD  
7:51 AM - 7:56 AM What Is New From The DREAM Trial: Are There Long-Term Survival Benefits Of EVAR?
  Presenters(s):Jan D. Blankensteijn, MD  
7:57 AM - 8:02 AM 5-Year Results Of The French ACE Trial Comparing EVAR With Open Repair In Standard Risk Patients
  Presenters(s):Jean-Pierre Becquemin, MD, FRCS  
8:03 AM - 8:08 AM What Is New From The OVER VA Trial Of EVAR vs. Open Repair For Standard Risk AAAs?
  Presenters(s):Frank A. Lederle, MD  
8:09 AM - 8:14 AM Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation 32.1 - Innovation In AAA Diagnosis And Treatment: What Does The Future Hold?
  Presenters(s):Vicente Riambau, MD, PhD  
Web-Based Presentation 32.2 - Does AAA Diameter Influence Long-Term Patient Survival After Elective EVAR And Open Repair?
  Presenters(s):Peter Polterauer, MD / Hans Teufelsbauer, MD / George Kretschmer, MD / Johannes Lammer, MD  
Web-Based Presentation 32.3 - Why Is The Mortality For Elective And Ruptured AAA Repair (Open And Endo) So Much Higher In Women? Can It Be Fixed?
  Presenters(s):Marc R.H. van Sambeek, MD, PhD  
Web-Based Presentation 32.4 - Tips And Tricks For Open Conversion After Failed EVAR
  Presenters(s):R. Clement Darling III, MD  
Web-Based Presentation 32.5 - Are Outcomes For Hemodynamically Stable Ruptured AAA Patients Different From Those Who Are Unstable?
  Presenters(s):Manish Mehta, MD, MPH  
END OF SESSION 32
 
SESSION 33 SCHEDULE
Saturday
SESSION 33: NEW DEVELOPMENTS IN THE TREATMENT OF THE AORTA AND ITS BRANCHES (5-MINUTE TALKS)
Moderators:Wesley S. Moore, MD / Jean-Pierre Becquemin, MD, FRCS  
x
8:14 AM - 8:19 AM A Telescoping Sutureless Aortic Anastomosis Using An Endograft Connector For Aortoiliac Occlusive Disease In Which The Aorta Cannot Be Clamped Or Sewn Due To Calcification Or Scarring: A New Hybrid Technique
  Presenters(s):Mario Lachat, MD  
8:20 AM - 8:25 AM Debate 24: Open Surgery Is Never Needed For Aortoiliac Occlusive Disease
  Presenters(s):Edward B. Diethrich, MD  
8:26 AM - 8:31 AM Debate 24: Aortoiliac Stents Are Not All They Are Cracked Up To Be: Open Surgery Is Sometimes Better
  Presenters(s):Rabih A. Chaer, MD / Michel S. Makaroun, MD  
8:32 AM - 8:37 AM Aortoiliac Occlusions Should First Be Treated Endovascularly: Do Any Require Open Surgery?
  Presenters(s):Götz M. Richter, MD, PhD  
8:38 AM - 8:43 AM Contemporary Management Of Splenic Artery Aneurysms: Indications For Endo And Open Treatment
  Presenters(s):Vikram S. Kashyap, MD  
8:44 AM - 8:49 AM A New Concept For A Branched Endograft For Left Subclavian Revascularization With TEVAR
  Presenters(s):Frank R. Arko, MD  
8:50 AM - 8:55 AM Minimally Invasive Treatment Of Visceral Aneurysms: When Can It Work, When Can It Not?
  Presenters(s):Samuel R. Money, MD, MBA  
8:56 AM - 9:01 AM Visceral Aneurysms: Role Of Open And Endovascular Treatments
  Presenters(s):Arno von Ristow, MD  
9:02 AM - 9:07 AM Panel Discussion
Moderator(s): Darren B. Schneider, MD / Ramesh K. Tripathi, MD, FRCS, FRACS  
9:08 AM - 9:13 AM Current Status Of Renal Artery Stenting: It Is Not Dead But Why Is It So Hard To Prove Its Value?
  Presenters(s):Peter A. Schneider, MD  
9:14 AM - 9:19 AM Improved Stents, Balloons And Embolic Protection Devices (EPDs) For Renal Artery Stenting
  Presenters(s):Thomas Zeller, MD  
9:20 AM - 9:25 AM Errors In Selection Criteria For Renal Artery PTA And Stenting: There Is Still A Role For Open Repair
  Presenters(s):James C. Stanley, MD  
9:26 AM - 9:31 AM Debate 25: There Is No Need For EPDs In Renal Artery Stenting If One Uses Optimal Techniques
  Presenters(s):Ali Amin, MD, RVT, FACS, FACC  
9:32 AM - 9:37 AM Debate 25: EPDs Should Be Used In Renal Artery Stenting Whenever Possible
  Presenters(s):Max Amor, MD  
9:38 AM - 9:43 AM For Chronic Visceral Ischemia When Is Endovascular Treatment Indicated And When Is Open Surgical Repair The Best Treatment?
  Presenters(s):Gustavo S. Oderich, MD  
9:44 AM - 9:55 AM Panel Discussion And Break – Visit Exhibits and Pavilions (2nd and 3rd Floors)
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation 33.1 - How Should Renal Artery In Stent Restenosis And Stent Fractures Be Best Treated?
  Presenters(s):Robert A. Lookstein, MD, FSIR, FAHA  
Web-Based Presentation 33.2 - Renal Artery Stents Perform Poorly: We Need Covered Or Otherwise Modified Stents
  Presenters(s):Ross Milner, MD  
Web-Based Presentation 33.3 - Should We Forget About Aortoiliac Endarterectomy?
  Presenters(s):Timothy M. Sullivan, MD  
Web-Based Presentation 33.4 - Indications And Value Of Hypogastric Artery Stenting
  Presenters(s):Götz M. Richter, MD, PhD  
Web-Based Presentation 33.5 - Flaws In The ASTRAL And CORAL Trials: Renal Artery Stenting Still Has A Role
  Presenters(s):Michael H. Wholey, MD, MBA  
Web-Based Presentation 33.6 - Upper Extremity Access For Renal Artery Stenting: Radial, Brachial And Axillary Access: How To Do Them Safely And Pitfalls To Avoid
  Presenters(s):Thomas A. Sos, MD  
Web-Based Presentation 33.7 - Tips And Tricks For Subintimal Angioplasty For Iliac Occlusions: Open Operation May Be Obsolete
  Presenters(s):Jean M. Panneton, MD  
Web-Based Presentation 33.8 - Iliac Artery Entrapment In Cyclists: Diagnosis And Treatment
  Presenters(s):Alun H. Davies, MA, DM, FRCS, FHEA  
Web-Based Presentation 33.9 - Importance Of Fractures In Renal Artery Stenting: How To Prevent Them
  Presenters(s):Michael H. Wholey, MD, MBA  
END OF SESSION 33
 
SESSION 34 SCHEDULE
Saturday
SESSION 34: THE FUTURE: ISSUES REGARDING HEALTH CARE CONCEPTS (5-MINUTE TALKS)
Moderators:Peter R.F. Bell, MD, FRCS, DSC, KBE / Patrick J. Lamparello, MD  
x
9:55 AM - 10:00 AM Debate 26: Should Major Vascular Procedures Be Centralized: Yes – It Is Best For All Concerned
  Presenters(s):Matt M. Thompson, MD  
10:01 AM - 10:06 AM Debate 26: Should Major Vascular Procedures Be Centralized: Hell No – It Can Never Be Done
  Presenters(s):Karl A. Illig, MD  
10:07 AM - 10:12 AM Impact Of Health Care Reform On Vascular Surgery And Its Practice
  Presenters(s):Robert M. Zwolak, MD, PhD  
10:13 AM - 10:18 AM What Is Health Care Reform All About: Will It Hurt Vascular Surgery, Health Care In General And Our Country: How?
  Presenters(s):Thomas J. Fogarty, MD  
10:19 AM - 10:24 AM Surgeon And Physician Interaction With Device And Pharmaceutical Companies: What Is Going On In Massachusetts And Is This The Canary In The Coal Mine Before The Explosion: What Can Be Done About It?
  Presenters(s):Thomas F. O'Donnell, Jr., MD  
10:25 AM - 10:30 AM A View From Industry: The Negative Impact And Unintended Consequences Of Health Care Reform: What Can Be Done About It?
  Presenters(s):Tammy S. Leitsinger, BSM  
10:31 AM - 10:36 AM Changes In Coding And Reimbursement For Endovascular Lower Extremity Intervention In 2011
  Presenters(s):Sean P. Roddy, MD  
10:36 AM - 10:44 AM Panel Discussion
END OF SESSION 34
 
SESSION 35 SCHEDULE
Saturday
SESSION 35: A TRIBUTE TO OUR MILITARY (5-MINUTE TALKS)
Moderators:David L. Gillespie, MD / Norman M. Rich, MD, FACS, DMCC  
x
10:44 AM - 10:49 AM Task Force Leatherneck: A Surgeon’s Perspective From Afghanistan
  Presenters(s):Stephen F. McCartney, MD, FACS  
10:50 AM - 10:55 AM Vascular Injury Rates In The Iraq And Afghanistan Wars: How Are They Different From The Past?
  Presenters(s):Todd E. Rasmussen, MD, FACS  
10:56 AM - 11:01 AM Some Historical Vignettes In Vascular Surgery: Who Did What First?
  Presenters(s):Norman M. Rich, MD, FACS, DMCC  
11:02 AM - 11:07 AM Panel Discussion
END OF SESSION 35
 
SESSION 36 SCHEDULE
Saturday
SESSION 36: COST, TRAINING, AND BUSINESS ISSUES (5-MINUTE TALKS)
Moderators:Robert M. Zwolak, MD, PhD / Karl A. Illig, MD  
x
11:08 AM - 11:13 AM How Can Device And Supply Costs For Endovascular Procedures Be Minimized By A Computerized Management System With Vascular Surgeon Input?
  Presenters(s):Jerry Goldstone, MD, FACS, FRCS E  
11:14 AM - 11:19 AM Simplified Billing And Coding Software To Facilitate Recordkeeping And Billing And Save Time And Energy In A Vascular Practice
  Presenters(s):Sam S. Ahn, MD, FACS, MBA  
11:20 AM - 11:25 AM Do Popular Media And Internet Hospital Quality Ratings Identify Hospitals With Better Cardiovascular Surgery Outcomes?
  Presenters(s):Gilbert R. Upchurch, MD  
11:26 AM - 11:31 AM FDA Perspective On Current Challenges Facing Clinical Evaluation Of Peripheral Vascular Devices
  Presenters(s):Kenneth J. Cavanaugh, Jr., PhD / Dorothy B. Abel, BSBME  
11:32 AM - 11:37 AM Robotics And Endovascular Navigation: Progress In And Importance For In Situ Fenestration And Other Complex Procedures
  Presenters(s):Nicholas J.W. Cheshire, MD  
11:38 AM - 11:43 AM 3D Endovascular Mechanical Simulator System (The Pontressina System): A Valuable New Approach To Improve Simulator Training
  Presenters(s):Hans-Henning Eckstein, MD, PhD  
11:44 AM - 11:49 AM How To Set Up A Comprehensive Diabetes Program
  Presenters(s):Peter Sheehan, MD  
11:50 AM - 11:55 AM Cost Impact Of Statins In AAA Repair: They Make A Difference
  Presenters(s):Michael C. Stoner, MD  
11:55 AM - 12:00 PM Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation 36.1 - How Can Endovascular Procedures Be Done Effectively And In A Freestanding Outpatient Facility To Keep It In The Black?
  Presenters(s):Russell H. Samson, MD, RVT, FACS  
END OF SESSION 36
 
SESSION 37 SCHEDULE
Saturday
SESSION 37: LUNCHEON LECTURES: NEW AND IMPROVED ENDOGRAFTS, TECHNIQUES AND DEVICES (5-MINUTE TALKS)
Moderators:Frans L. Moll, MD, PhD / Giorgio M. Biasi, MD  
x
12:00 PM - 12:05 PM The Improved TRIVASCULAR Graft: History, Improvements, Advantages And Recent And Long-Term Clinical Experience
  Presenters(s):Michael D. Dake, MD / Francisco Valdes, MD  
12:06 PM - 12:11 PM The NELLIX EVAR Endoprosthesis For Filling The AAA Sac With Polymer Filled Endobags While Maintaining Flow Through Stents: Technique, Early Results And Advantages
  Presenters(s):Carlos E. Donayre, MD  
12:12 PM - 12:17 PM Contemporary 1-Year EVAR Outcomes From The U.S. IDE Trial And ENGAGE Global Registry Of The ENDURANT AAA Endograft Device
  Presenters(s):Michel S. Makaroun, MD / Vicente Riambau, MD, PhD  
12:18 PM - 12:23 PM Update On The US RELAY Trial For TEVAR
  Presenters(s):Mark A. Farber, MD  
12:24 PM - 12:29 PM Multicenter Clinical Experience With A Novel Repositionable AAA Endograft From W.L. Gore & Associates
  Presenters(s):Eric L.G. Verhoeven, MD, PhD / Mark F. Fillinger, MD  
12:30 PM - 12:35 PM Advantages Of The Improved COOK TX2 Device For TEVAR
  Presenters(s):Karl A. Illig, MD  
12:36 PM - 12:41 PM Advantages And Limitations Of The ANACONDA AAA Endograft
  Presenters(s):Donald B. Reid, MD  
12:42 PM - 12:47 PM Update On The APTUS Devices And Trials
  Presenters(s):Mark A. Adelman, MD  
12:48 PM - 12:53 PM Update On The Aorfix AAA Graft For Angulated Necks And Severe Iliac Angulation: The European 8-Year Results
  Presenters(s):Brian R. Hopkinson, ChM, FRCS  
12:54 PM - 12:59 PM Off-The-Shelf Fenestrated Device From Endologix For Treatment Of Pararenal And Juxtarenal AAAs: Initial Clinical Experience
  Presenters(s):Daniel G. Clair, MD  
12:59 PM - 1:04 PM Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation 37.1 - Advantages Of The Cook ZENITH LP Device For AAAs
  Presenters(s):Ronald M. Fairman, MD  
Web-Based Presentation 37.2 - Update On The US ANACONDA Trial
  Presenters(s):Christopher J. Kwolek, MD  
Web-Based Presentation 37.3 - 3-Year Results With The Cook RENU Proximal Cuff Device For Treating Failed/Migrated Endografts Without Or With Type I Leaks
  Presenters(s):Luis A. Sanchez, MD  
Web-Based Presentation 37.4. - European Experience With The RELAY Endograft In 304 TEVAR Cases
  Presenters(s):Vicente Riambau, MD, PhD  
Web-Based Presentation 37.5 - Significant Reduction Of Aneurysm Volumes After EVAR With Excluder Low Permeability Graft: Comparison With Original Excluder After 4 Years Of Follow-Up
  Presenters(s):Zvonimir Krajcer, MD, FACC  
Web-Based Presentation 37.6 - One-Year Clinical Experience With The TriVascular OvationT Abdominal Stent Graft
  Presenters(s):Francisco Valdes, MD  
END OF SESSION 37
 
SESSION 38 SCHEDULE
Saturday
SESSION 38: ETHICS, STANDARDS, CONCEPTS, MALPRACTICE (5-MINUTE TALKS)
Moderators:Julius H. Jacobson II, MD / Norman M. Rich, MD, FACS, DMCC  
x
1:05 PM - 1:09 PM Off-Label Device Use: An FDA Division of Cardiovascular Devices Perspective
  Presenters(s):Dorothy B. Abel, BSBME  
1:10 PM - 1:15 PM Are There Alternate Pathways To FDA Approval Of Vascular Devices That We Can Use?
  Presenters(s):Rodney A. White, MD  
1:16 PM - 1:21 PM Off-Label Use Of A Drug Or Device Or Use Of A New Device With Little Experience Can Lead To Malpractice Liability
  Presenters(s):O. William Brown, MD, JD  
1:22 PM - 1:27 PM How To Be A Good Expert Witness
  Presenters(s):Karl A. Illig, MD  
1:28 PM - 1:33 PM Surgical Infomercials The Ethical Price Of Stardom: But Are They Right?
  Presenters(s):James W. Jones, MD, PhD, MHA  
1:34 PM - 1:39 PM The Social (Public) Media And Their Impact On Patient Care, Patient Recruitment And Patient-Physician Interaction
  Presenters(s):Grayson H. Wheatley, MD  
1:40 PM - 1:45 PM Does Stent Placement Have A Learning Curve: What Mistakes Do We As Operators Make And How Can They Be Avoided?
  Presenters(s):Lewis B. Schwartz, MD  
1:46 PM - 1:51 PM Is Red Wine Really Helpful For Vascular Disease Patients: Why And What Dose Is Best?
  Presenters(s):Bauer E. Sumpio, MD, PhD  
1:52 PM - 1:57 PM Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation 38.1 - What Motivates Us As Vascular Specialists To Perform Procedures Other Than Patient Benefit?
  Presenters(s):Frank J. Veith, MD  
Web-Based Presentation 38.2 - Are Some Centers With Good Mortality And Morbidity Results For AAA Repair, Etc., Guilty Of Turning Down Bad Patients: Does This Render Quality Evaluations Difficult?
  Presenters(s):Matt M. Thompson, MD  
Web-Based Presentation 38.3 - Assessing Quality And Risk In Our Health Care System: The Good, The Bad And The Ugly: Is PFP Going To Be Fair And Beneficial Or Bad?
  Presenters(s):Ralph G. DePalma, MD  
END OF SESSION 38
 
SESSION 39 SCHEDULE
Saturday
SESSION 39: VASCULAR DISEASE NATURAL HISTORY, MEDICAL TREATMENT, PREVENTION AND TREATMENT OF COMPLICATIONS (5-MINUTE TALKS)
Moderators:Peter R.F. Bell, MD, FRCS, DSC, KBE / Sharif H. Ellozy, MD  
x
1:58 PM - 2:03 PM Can Medication Stabilize Or Reverse Vascular Disease: With Lipid Lowering How Low Should You Go?
  Presenters(s):Russell H. Samson, MD, RVT, FACS  
2:04 PM - 2:09 PM RHEOS Trial Update: Carotid Sinus Stimulation For Treatment Of Drug Resistant Hypertension: Does It Work?
  Presenters(s):Luis A. Sanchez, MD  
2:10 PM - 2:15 PM Influence Of ACE Inhibitors And Statins On AAA Growth And Rupture Risk: Do They Make A Difference And Why?
  Presenters(s):Janet T. Powell, MD, PhD  
2:16 PM - 2:21 PM Are ACE Inhibitors Of Value In Patients With Thoracic Aortic Aneurysms?
  Presenters(s):Iris Baumgartner, MD  
2:22 PM - 2:27 PM Is The Cervical Approach For CAS With Flow Reversal Safer For The Brain Than Other CAS Approaches: Based On DWI MRI
  Presenters(s):Enrique Criado, MD, FACS  
2:28 PM - 2:33 PM ONYX As An Adjunct In Treating Type I And Type II Endoleaks, Ruptured AAAs And Arterial Injuries: An Update
  Presenters(s):Thomas Larzon, MD  
2:34 PM - 2:39 PM New Developments In Statin Treatment Of Importance To Vascular Specialists And Their Patients: Which Statin; What Dosage?
  Presenters(s):Kosmas I. Paraskevas, MD  
2:40 PM - 2:45 PM Endovascular Solutions To Aortoiliac Complications From Spine Surgery
  Presenters(s):Neal S. Cayne, MD  
2:46 PM - 2:51 PM Drug Eluting Stents Are Great For Coronary Artery Disease Patients But Trouble For Vascular Surgeons: How To Get Them Through Surgery If They Have A Drug Eluting Stent
  Presenters(s):Jean-Pierre Becquemin, MD, FRCS  
2:52 PM - 2:57 PM Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS AND SLIDES THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation 39.1 - Can Hybrid Open Chest Procedures Be Done Safely In A Modified Angio Suite?
  Presenters(s):Barry T. Katzen, MD  
Web-Based Presentation 39.2 - Vascular Surgeons Must Lead The Efforts For Their Patients To Get Proper Statin Treatment
  Presenters(s):Anthony J. Comerota, MD, FACS, FACC  
Web-Based Presentation 39.3 - What Is The Role Of A Cervical Approach For CAS: How To Do It Safely?
  Presenters(s):Mark H. Wholey, MD  
Web-Based Presentation 39.4 - Endovascular Rescue Of Inadvertent Arterial Sheath Placement During Central Venous Catheterization: How To Recognize And Treat
  Presenters(s):Tilo Kölbel, MD, PhD  
Web-Based Presentation 39.5 - Effect Of Statins On Early And Late Results Of CAS
  Presenters(s):Piergiorgio Cao, MD, FRCS  
Web-Based Presentation 39.6 - How To Solve The Problem Of Catching Or Snagging Wires During EVAR
  Presenters(s):Barry T. Katzen, MD  
END OF SESSION 39
 
SESSION 40 SCHEDULE
Saturday
SESSION 40: UPDATES, NEW TECHNIQUES AND CONCEPTS (5-MINUTE TALKS)
Moderators:George H. Meier III, MD / Lucien D. Castellani, MD  
x
2:57 PM - 3:02 PM Have Endovascular Treatments Altered The Management And Outcomes Of Acute Mesenteric Ischemia?
  Presenters(s):Daniel G. Clair, MD  
3:03 PM - 3:08 PM Transvenous Transcaval Approach To AAA Sacs After EVAR To Treat Type II Endoleaks
  Presenters(s):Giancarlo Mansueto, MD  
3:09 PM - 3:14 PM What Happens To The Femoral Artery With Manual Compression Hemostasis After Endovascular Procedures; Is It Totally Benign?
  Presenters(s):Dusan Pavcnik, MD, PhD  
3:15 PM - 3:20 PM Unusual Uses Of The ANACONDA Endograft And Its Components In Special Circumstances
  Presenters(s):Andrea Stella, MD  
3:21 PM - 3:26 PM Use Of Covered Palmaz Stent (VI-Maquet) For Solving Difficult Neck Problems With EVAR
  Presenters(s):Giovanni P. Deriu, MD  
3:27 PM - 3:32 PM Use Of Covered And Uncovered Palmaz Stents To Resolve Difficult Neck Problems With EVAR: When Is A Covered Stent Needed?
  Presenters(s):Dieter Raithel, MD, PhD  
3:33 PM - 3:38 PM Femoro-femoral Stabilizing Second Wire For Complex Hypogastric Artery Embolizations: Advantages And Technique
  Presenters(s):Jon S. Matsumura, MD  
3:39 PM - 3:44 AM What To Do During CAS With Flow Reversal If It Is Not Tolerated – Especially With Contralateral ICA Occlusion: How Can The Procedure Be Completed Safely With Embolic Protection?
  Presenters(s):Karthikeshwar Kasirajan, MD  
3:45 PM - 3:50 PM Panel Discussion
Moderator(s): John E. Connolly, MD / Donna M. Mendes, MD, FACS  
3:50 PM - 3:55 PM Debate 27: Suprarenal Fixation Is Best For Angled Necks
  Presenters(s):Bjõrn Sonesson, MD, PhD / Martin Malina, MD, PhD  
3:56 PM - 4:01 PM Debate 27: Suprarenal Fixation Is Not Best For Angled Necks
  Presenters(s):Robert Y. Rhee, MD  
4:02 PM - 4:07 PM Femoral Endarterectomy And Iliac Stent-Grafting vs. Aortobifemoral Bypass: When Should The Former Replace The Latter?
  Presenters(s):Richard J. Powell, MD  
4:08 PM - 4:13 PM New Developments With The CARDIOMEMS Pressure Monitoring Device: When Is Its Use Beyond A Research Tool Justified?
  Presenters(s):Ross Milner, MD  
4:14 PM - 4:19 PM Coiling Techniques To Treat Endoleaks After EVAR: Tips And Tricks To Make Them Work
  Presenters(s):Jörn O. Balzer, MD, PhD  
4:20 PM - 4:25 PM The Truth About EVAR Surveillance From The European Survey Analysis: Is It Really A Good Thing?
  Presenters(s):Vicente Riambau, MD, PhD  
4:26 PM - 4:31 PM Duplex Ultrasound To Guide Treatment Of Popliteal Entrapment
  Presenters(s):Niten Singh, MD  
4:32 PM - 4:37 PM Clinical Importance Of Vein Graft Arterialization: How Good Is It; How Bad Can It Be?
  Presenters(s):Alan Dardik, MD, PhD  
4:38 PM - 4:43 PM Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation 40.1 - Use Of Covered Palmaz Stent (VI-Maquet) For Solving Difficult Neck Problems
  Presenters(s):Afshin Assadian, MD  
Web-Based Presentation 40.2 - The European View Of CAS vs. CEA In Light Of All The Trials
  Presenters(s):Jan S. Brunkwall, MD, PhD  
Web-Based Presentation 40.3 - What Is The Best Technique For Measuring Intra-abdominal Pressure (IAP) And What Is The Relationship Between IAP And Colonic Perfusion?
  Presenters(s):Martin Björck, MD, PhD  
Web-Based Presentation 40.4 - Is EVAR Indicated For Aortoduodenal Fistulas?
  Presenters(s):Jacques Busquet, MD  
Web-Based Presentation 40.5 - AUI vs. Bifurcated Endografts For Treating Ruptured AAAs: Which Is Best?
  Presenters(s):Vicente Riambau, MD, PhD  
END OF SESSION 40
 
SESSION 41 SCHEDULE
Saturday
SESSION 41: MORE UPDATES AND NEW TECHNOLOGY (5-MINUTE TALKS)
Moderators:Frank J. Veith, MD / Michael B. Silva, Jr., MD  
x
4:44 PM - 4:49 PM Improved Technique For Treating Vascular Graft Infection With An Endograft, Debridement And A VAC Dressing
  Presenters(s):Martin Björck, MD, PhD  
4:50 PM - 4:55 PM When Is Intervention Indicated For Restenosis After An Endovascular Treatment?
  Presenters(s):Joseph L. Mills, MD  
4:56 PM - 5:01 PM Do Outcomes Of Lower Extremity Revascularizations Differ In Men And Women?
  Presenters(s):Vivian Gahtan, MD  
5:02 PM - 5:07 PM After EVAR When Is “Fix It And Forget It”, i.e. No Surveillance An Acceptable Strategy?
  Presenters(s):Jean-Pierre Becquemin, MD, FRCS  
5:08 PM - 5:13 PM Correlates Of AAA Thrombus Thickness And Location With Endoleak After EVAR
  Presenters(s):Ali F. AbuRahma, MD  
5:14 PM - 5:19 PM Triple Fenestrated Endografts In The Treatment Of Juxtarenal AAAs: Advantages And Limitations
  Presenters(s):Peter L. Harris, MD, FRCS  
5:20 PM - 5:25 PM Through-The-Knee Amputation From A Posterior Approach: A Better Alternative Than Above-Knee Amputation
  Presenters(s):Carlos E. Donayre, MD  
5:26 PM - 5:30 PM Panel Discussion
Moderator(s): Daniel G. Clair, MD / Mohan Adiseshiah, FRCS  
5:30 PM - 5:35 PM Tips And Tricks For Visceral Artery Stenting
  Presenters(s):Michael H. Wholey, MD, MBA  
5:36 PM - 5:41 PM Fast Track Concept Can Make Open Aortic Surgery Comparable To Endovascular And Laparoscopic Aortic Surgery
  Presenters(s):Sebastian E. Debus, MD, PhD  
5:42 PM - 5:47 PM Sphingosine-1-Phosphate (S-1-P) And VEGF Offer Promise For Effective Angiogenesis In CLI
  Presenters(s):Renan Uflacker, MD  
5:48 PM - 5:53 PM Hostile Neck Anatomy Is Less Of A Contraindication To EVAR With Newer Endografts Than It Was: What Are The New Limits For Acceptable Neck Angulation?
  Presenters(s):Hence J.M. Verhagen, MD, PhD  
5:54 PM - 5:59 PM Endovascular Repair Of Penetrating Atherosclerotic Ulcers In The Infrarenal Aorta And Iliac Arteries: When And How Should They Be Treated?
  Presenters(s):Afshin Assadian, MD  
6:00 PM - 6:05 PM Remote SFA Endarterectomy With The Moll Ring Cutter: Technique And Results
  Presenters(s):Jean-Paul deVries, MD, PhD  
6:06 PM - 6:11 PM Experience With The Use Of The Multilayer Stent For The Treatment Of Peripheral And Visceral Aneurysms
  Presenters(s):Claudio Rabbia, MD, PhD  
6:12 PM - 6:17 PM Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation 41.1 - CO2 Angiography Is Simple And Safe: How To Do It Effectively: Techniques And Precautions
  Presenters(s):Kim J. Hodgson, MD  
Web-Based Presentation 41.2 - Bailout Options For Overstented Vital Aortic Branches
  Presenters(s):Martin Malina, MD, PhD  
Web-Based Presentation 41.3 - Molecular Mechanisms Of AAA Formation: An Update And Will There Ever Be Effective Medical Treatment?
  Presenters(s):Elliot L. Chaikof, MD, PhD  
Web-Based Presentation 41.4 - How To Set Up A Program Of Independent Neurological Evaluation For CAS Trials
  Presenters(s):Christopher J. Kwolek, MD  
Web-Based Presentation 41.5 - Antiplatelet Treatment For Secondary Risk Prevention In Vascular Patients: Which Drug, What Dose, How Long?
  Presenters(s):Russell H. Samson, MD, RVT, FACS  
END OF SESSION 41